… (C60–C63) at 38.8% (n=650), which almost entirely consisted of prostate cancer (38.0%; n=637), and malignant neoplasms of digestive organs at …
myelodysplastic syndromes
This disease is selected. Its supporting articles are shown below.
Articles mentioning myelodysplastic syndromes
5 articles · page 1 of 1…dagrasib, evaluated in KRYSTAL-1, showed comparable efficacy in NSCLC (ORR ~43%, PFS 6.5 months, OS 12.6 months) and similarly receiv…
…rrow niche alterations and hematopoietic clonal dynamicsResults Melanoma tumor cells infiltrate the bone marrow early, with disseminated…
… commonly used for treating myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML). There is conflicting evidence regarding its impact on ca…
…acute myeloid leukaemia (AML) (1%–19% blasts) and 71% (351/495) AML (≥20% blasts), with 18% (81/460) having low CK50. Overall, 83% …